go-v.orgdoi

Sublingual Therapeutics: A Gateway To Enhanced Drug Absorption

Neeraj K. Vishwakarma, Pravin Kumar Sharma, Sumeet Dwivedi, Ashish K Gupta, G. N. Darwhekar · European journal of parenteral & pharmaceutical sciences · 2025

  • DOI 10.37521/ejpps30215
  • Publisher OpenAlex
  • Type article
  • Issued 2025

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2025

Abstract

Sublingual drug delivery holds promise for facilitating quicker and more direct absorption of medications into the bloodstream. The sublingual area in the mouth enhances drug absorption, bypassing the liver's first-pass metabolism, resulting in higher bioavailability and improved patient compliance. Sublingual medications can help children, the elderly, and individuals with mental health disorders or those that have dysphasia. Over time, these new options help in improving treatment management by making medication easier and more convenient. Because of their potential for emergency treatment, there is a growing demand for sublingual drug delivery.

In contrast to the oral cavity's palatal and buccal areas, the sublingual region is more permeable; thus, fast-dissolving sublingual tablets have the potential to significantly outperform existing treatment options for certain patient populations, including elderly and paediatric patients. Keywords: Sublingual drug delivery, absorption of drug, superior permeability, avoid hepatic first-pass metabolism, bioavailability.

Open the resolved locator · 10.37521/ejpps30215

Metadata licence: OpenAlex metadata (CC0)